RT @RichardPAConway: Stimakovits et al. Influence of placebo vs active comparator in RA clinical trials. ACR response ra
Tweet Content
Stimakovits et al. Influence of placebo vs active comparator in RA clinical trials. ACR response rates systematically higher in studies with active comparators. ACR20 OR 1.64 (1.44-1.86), ACR50 OR 1.46 (1.28-1.71), ACR70 OR 1.61 (1.28-2.02) @RheumNow #EULAR2022 POS0563 https://t.co/x7PQH11oue
Show on Archive Page
On
Display in Search Results
On
PDQ
Off